Mechanistic comparison of Medroxyprogesterone Acetate and Progesterone based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
23
Shared Targets
27%
Jaccard Similarity
20%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Medroxyprogesterone and Progesterone share 23 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.267 means 27% of the combined target set is bound by both compounds. The IDF-weighted score of 0.202 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Medroxyprogesterone and Progesterone have in common?
Medroxyprogesterone and Progesterone share 23 molecular targets with a Jaccard similarity of 27%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Medroxyprogesterone and Progesterone be combined?
Medroxyprogesterone and Progesterone share 23 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Medroxyprogesterone or Progesterone?
Both Medroxyprogesterone and Progesterone have substantial PubMed research. View their individual profiles for full evidence scores.